Atagabalin (PD-0200,390) is a drug developed by
Pfizer and related to
gabapentin, which similarly binds to the α
2δ
calcium channel
A calcium channel is an ion channel which shows selective permeability to calcium ions. It is sometimes synonymous with voltage-gated calcium channel, although there are also ligand-gated calcium channels.
Comparison tables
The following tables e ...
s (
1 and
2).
It was under development as a treatment for
insomnia,
but was discontinued following unsatisfactory trial results.
See also
*
4-Methylpregabalin
*
Gabapentin enacarbil
*
PD-217,014
References
Abandoned drugs
Amino acids
Calcium channel blockers
GABA analogues
Hypnotics
Pfizer brands
Cyclopentanes
{{sedative-stub